89BIO, INC. - Annual Financials - Balance Sheet (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

89BIO, INC. - Annual Balance Sheet (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	126060	316161
Marketable securities	313895	262709
Prepaid and other current assets	36495	14664
Total current assets	476450	593534
Operating lease right-of-use assets	1572	2293
Property and equipment, net	23	46
Other assets	640	396
Total assets	478685	596269
Accounts payable	15382	8585
Accrued expenses	20020	20530
Operating lease liabilities, current	727	496
Total current liabilities	36129	29611
Operating lease liabilities, noncurrent	1090	1817
Warrant liability	516	0
Term loan, noncurrent, net	35732	24795
Other noncurrent liabilities	4429	3740
Total liabilities	77896	59963
Commitments and contingencies (Note 5)	0	0
Preferred stock, $0.001 par value: 10,000,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.001 par value: 200,000,000 shares authorized; 119,849,436 and 93,269,377 shares issued and outstanding as of December 31, 2024 and 2023, respectively	120	93
Additional paid-in capital	1224617	993455
Accumulated other comprehensive income	563	190
Accumulated deficit	-824511	-457432
Total stockholders equity	-824511	536306	467374
Total liabilities and stockholders equity	478685	596269
Preferred stock, par value	0	0
Preferred stock, shares authorized	10000	10000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	0	0
Common stock, shares authorized	200000	200000
Common stock, shares issued	119849.436	93269.377
Common stock, shares outstanding	119849.436	93269.377